Compare Aventis Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ABBOTT INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ABBOTT INDIA SANOFI INDIA/
ABBOTT INDIA
 
P/E (TTM) x 35.9 48.1 74.6% View Chart
P/BV x 6.3 13.8 45.6% View Chart
Dividend Yield % 1.4 0.5 276.6%  

Financials

 SANOFI INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ABBOTT INDIA
Mar-18
SANOFI INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6,8406,110 111.9%   
Low Rs4,6303,996 115.9%   
Sales per share (Unadj.) Rs1,203.11,552.2 77.5%  
Earnings per share (Unadj.) Rs165.3188.8 87.5%  
Cash flow per share (Unadj.) Rs209.9196.4 106.8%  
Dividends per share (Unadj.) Rs84.0055.00 152.7%  
Dividend yield (eoy) %1.51.1 134.6%  
Book value per share (Unadj.) Rs963.6796.6 121.0%  
Shares outstanding (eoy) m23.0321.25 108.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.3 146.4%   
Avg P/E ratio x34.726.8 129.7%  
P/CF ratio (eoy) x27.325.7 106.2%  
Price / Book Value ratio x6.06.3 93.8%  
Dividend payout %50.829.1 174.5%   
Avg Mkt Cap Rs m132,078107,376 123.0%   
No. of employees `0003.33.3 99.4%   
Total wages/salary Rs m4,0683,937 103.3%   
Avg. sales/employee Rs Th8,393.89,929.3 84.5%   
Avg. wages/employee Rs Th1,232.41,185.1 104.0%   
Avg. net profit/employee Rs Th1,153.01,207.7 95.5%   
INCOME DATA
Net Sales Rs m27,70832,985 84.0%  
Other income Rs m8971,170 76.7%   
Total revenues Rs m28,60534,155 83.8%   
Gross profit Rs m6,2355,245 118.9%  
Depreciation Rs m1,027162 634.3%   
Interest Rs m738 18.3%   
Profit before tax Rs m6,0986,215 98.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2922,203 104.1%   
Profit after tax Rs m3,8064,012 94.9%  
Gross profit margin %22.515.9 141.5%  
Effective tax rate %37.635.4 106.0%   
Net profit margin %13.712.2 112.9%  
BALANCE SHEET DATA
Current assets Rs m15,92222,655 70.3%   
Current liabilities Rs m6,2356,681 93.3%   
Net working cap to sales %35.048.4 72.2%  
Current ratio x2.63.4 75.3%  
Inventory Days Days6465 98.3%  
Debtors Days Days2129 71.6%  
Net fixed assets Rs m7,539835 902.4%   
Share capital Rs m230213 108.2%   
"Free" reserves Rs m21,96216,715 131.4%   
Net worth Rs m22,19216,928 131.1%   
Long term debt Rs m00-   
Total assets Rs m29,83924,162 123.5%  
Interest coverage x872.1163.7 532.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.4 68.0%   
Return on assets %12.816.8 76.2%  
Return on equity %17.223.7 72.4%  
Return on capital %27.536.9 74.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,587369 2,058.7%   
Fx outflow Rs m7,1453,807 187.7%   
Net fx Rs m442-3,438 -12.9%   
CASH FLOW
From Operations Rs m3,7391,527 244.9%  
From Investments Rs m-731-2,148 34.0%  
From Financial Activity Rs m-1,972-1,024 192.5%  
Net Cashflow Rs m1,036-1,646 -63.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 7.9 182.3%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.1 61.4%  
Shareholders   15,184 18,270 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFESCIENCES  PANACEA BIOTECH  WOCKHARDT  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 17, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS